Glenmark Life Sciences Limited (GLS.BO)
INR 1021.7
(-0.42%)
INR 1021.7
(-0.42%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 171.48 Million INR | -11.41% |
| 2022 | 193.57 Million INR | 571.19% |
| 2021 | 28.84 Million INR | -99.69% |
| 2020 | 9.32 Billion INR | 4442123.81% |
| 2019 | 210 Thousand INR | 0.0% |
| 2018 | 210 Thousand INR | -98.55% |
| 2017 | 14.5 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 25.97 Million INR | 0.0% |
| 2023 Q2 | 182.84 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 171.48 Million INR | -11.41% |
| 2023 Q4 | 171.48 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 74.49 Million INR | 0.0% |
| 2022 FY | 193.57 Million INR | 571.19% |
| 2022 Q4 | 193.57 Million INR | 0.0% |
| 2021 Q2 | 36.38 Million INR | 0.0% |
| 2021 FY | 28.84 Million INR | -99.69% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 28.84 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | 0.0% |
| 2020 Q4 | 9.32 Billion INR | 4442123.81% |
| 2020 Q3 | 210 Thousand INR | 0.0% |
| 2020 FY | 9.32 Billion INR | 4442123.81% |
| 2019 FY | 210 Thousand INR | 0.0% |
| 2018 FY | 210 Thousand INR | -98.55% |
| 2017 FY | 14.5 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | 51.395% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -892.189% |
| Sigachi Industries Limited | 1.43 Billion INR | 88.013% |
| Bal Pharma Limited | 1.39 Billion INR | 87.721% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -3.167% |
| Medico Remedies Limited | 80.5 Million INR | -113.008% |
| Lasa Supergenerics Limited | 220.76 Million INR | 22.324% |
| Venus Remedies Limited | 413.3 Million INR | 58.51% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 71.957% |
| Alpa Laboratories Limited | 52.46 Million INR | -226.846% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 97.302% |
| Shilpa Medicare Limited | 9.37 Billion INR | 98.171% |
| Aarti Drugs Limited | 5.64 Billion INR | 96.961% |
| Lupin Limited | 29.21 Billion INR | 99.413% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 99.742% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 97.868% |
| Windlas Biotech Limited | 36.41 Million INR | -370.97% |
| Suven Life Sciences Limited | 7.09 Million INR | -2316.232% |
| Eris Lifesciences Limited | 27.81 Billion INR | 99.383% |
| Valiant Laboratories Limited | 767.08 Million INR | 77.645% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 95.459% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 98.305% |
| Ipca Laboratories Limited | 14.38 Billion INR | 98.808% |
| Bliss GVS Pharma Limited | 998.4 Million INR | 82.825% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.476% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 94.848% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | 91.723% |
| Laurus Labs Limited | 25.77 Billion INR | 99.335% |
| Piramal Pharma Limited | 47.1 Billion INR | 99.636% |
| Syncom Formulations (India) Limited | 724.86 Million INR | 76.343% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.574% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 96.658% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 98.607% |
| Unichem Laboratories Limited | 2.47 Billion INR | 93.072% |
| Sequent Scientific Limited | 4.87 Billion INR | 96.484% |
| Novartis India Limited | 69.7 Million INR | -146.026% |
| Wanbury Limited | 1.16 Billion INR | 85.279% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | 73.617% |
| Wockhardt Limited | 23.56 Billion INR | 99.272% |
| Themis Medicare Limited | 957.92 Million INR | 82.099% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -91.791% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 99.532% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.143% |
| Divi's Laboratories Limited | 30 Million INR | -471.6% |
| NATCO Pharma Limited | 3.71 Billion INR | 95.38% |
| Gufic Biosciences Limited | 3.32 Billion INR | 94.849% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 47.656% |
| Ind-Swift Limited | 10.13 Billion INR | 98.309% |
| Procter & Gamble Health Limited | 95.6 Million INR | -79.372% |
| FDC Limited | 205.18 Million INR | 16.427% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 91.135% |
| Granules India Limited | 13.15 Billion INR | 98.696% |
| Medicamen Biotech Limited | 308.17 Million INR | 44.356% |
| Alkem Laboratories Limited | 14.18 Billion INR | 98.791% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -272.929% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -3807.04% |
| Brooks Laboratories Limited | 56.41 Million INR | -203.94% |
| Megasoft Limited | 1.47 Billion INR | 88.338% |
| ZIM Laboratories Limited | 1.08 Billion INR | 84.243% |
| Strides Pharma Science Limited | 25.16 Billion INR | 99.319% |
| Neuland Laboratories Limited | 953.89 Million INR | 82.023% |
| Morepen Laboratories Limited | 289.99 Million INR | 40.867% |
| Hikal Limited | 8.17 Billion INR | 97.903% |
| Indoco Remedies Limited | 6.71 Billion INR | 97.448% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 93.988% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | 45.814% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | 82.59% |
| Hester Biosciences Limited | 2.44 Billion INR | 92.983% |